Comparison of three fluorescent CYP3A substrates in two vertebrate models: Pig and Atlantic salmon

Animal

Volumn 6, Issue 4, 2012, Pages 633-640

  Zlabek, V ^a,b   Zamaratskaia, G ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b UNIVERSITY OF SOUTH BOHEMIA   (Czech Republic)

Author keywords

7 benzyloxy 4 trifluoromethylcoumarin; 7 benzyloxyquinoline; 7 benzyloxyresorufin; 7 ethoxyresorufin; ketoconazole

Indexed keywords

7 BENZYLOXYQUINOLINE; 7-BENZYLOXYQUINOLINE; CYTOCHROME P450 1A1; CYTOCHROME P450 2B1; CYTOCHROME P450 3A; KETOCONAZOLE; QUINOLINE DERIVATIVE;

ANIMAL; ARTICLE; ATLANTIC SALMON; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KINETICS; LIVER MICROSOME; MALE; METABOLISM; SEX DIFFERENCE; SPECIES DIFFERENCE; SWINE;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2B1; CYTOCHROME P-450 CYP3A; FEMALE; KETOCONAZOLE; KINETICS; MALE; MICROSOMES, LIVER; QUINOLINES; SALMO SALAR; SEX FACTORS; SPECIES SPECIFICITY; SWINE;

SALMO SALAR; SUIDAE; SUS; VERTEBRATA;

EID: 84857856048     PISSN: 17517311     EISSN: 1751732X     Source Type: Journal    
DOI: 10.1017/S1751731111002096     Document Type: Article

References (37)

1. Abadie-Viollon C, Martin H, Blanchard N, Pekthong D, Bachellier P, Mantion G, Heyd B, Schuler F, Coassolo P, Alexandre E and Richert L 2010. Follow-up to the pre-validation of a harmonised protocol for assessment of CYP induction responses in freshly isolated and cryopreserved human hepatocytes with respect to culture format, treatment, positive reference inducers and incubation conditions. Toxicology in Vitro 24, 346-356.
2. Appiah-Opong R, Commandeur JNM, van Vugt-Lussenburg B and Vermeulen NPE 2007. Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products. Toxicology 235, 83-91. (Pubitemid 46669770)
3. Beijer K, Abrahamson A, Brunström B and Brandt I 2010. CYP1A inhibition in fish gill filaments: a novel assay applied on pharmaceuticals and other chemicals. Aquatic Toxicology 96, 145-150.
4. Burke MD, Thompson S, Weaver RJ, Wolf CR and Mayers RT 1994. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochemistry and Pharmacology 48, 923-936. (Pubitemid 24285170)
5. Chirulli V, Longo V, Marini S, Mazzaccaro A, Fiorio R and Gervasi PG 2005. CAR and PXR expression and inducibility of CYP2B and CYP3A activities in rat and rabbit lungs. Life Sciences 76, 2535-2546. (Pubitemid 40354256)
6. Christen V, Oggier DM and Fent K 2009. A microtiter-plate-based cytochrome P450 3A activity assay in fish cell lines. Environmental Toxicology and Chemistry 28, 2632-2638.
7. Di Mattina M, Maronian N, Ashby H, Loriaux DL and Albertson BD 1988. Ketoconazole inhibits multiple steroidogenic enzymes involved in androgen biosynthesis in the human ovary. Fertility and Sterility 49, 62-65. (Pubitemid 18033891)
8. Dresser GK, Spence JD and Bailey DG 2000. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clinical Pharmacokinetics 38, 41-57. (Pubitemid 30055093)
9. Easterbrook J, Lu C, Sakai Y and Li AP 2001. Effects of organic solvents on the activities of cytochrome P450 isoforms, UDP-dependent glucuronyl transferase, and phenol sulfotransferase in human hepatocytes. Drug Metabolism and Disposition 29, 141-144. (Pubitemid 32112927)
10. Förlin L and Celander M 1993. Induction of cytochrome P450 1A in teleosts: environmental monitoring in Swedish fresh, brackish and marine waters. Aquatic Toxicology 26, 41-56. (Pubitemid 23205250)
11. Gillberg M, Skaanild MT and Friis C 2006. Regulation of gender-dependent CYP2A expression in pigs: involvement of androgens and CAR. Basic & Clinical Pharmacology & Toxicology 98, 480-487.
12. Greenblatt DJ, Venkatakrishnan K, Harmatz JS, Parent SJ and von Moltke LL 2010. Sources of variability in ketoconazole inhibition of human cytochrome P450 3A in vitro. Xenobiotica 40, 713-720.
13. Hagemeyer CE, Bürck C, Schwab R, Knoth R and Meyer RP 2010. 7-Benzyloxyresorufin-O-dealkylase activity as a marker for measuring cytochrome P450 CYP3A induction in mouse liver. Analytical Biochemistry 398, 104-111.
14. Hasselberg L, Grøsvik BE, Goksøyr A and Celander MC 2005. Interactions between xenoestrogens and ketoconazole on hepatic CYP1A and CYP3A, in juvenile Atlantic cod (Gadus morhua). Comparative Hepatology 4, 2. doi:10.1186/1476-5926-4-2. (Pubitemid 41460770)
15. Havelkova M, Randak T, Zlabek V, Krijt J, Kroupova H, Pulkrabova J and Svobodova Z 2007. Biochemical markers for assessing aquatic contamination. Sensors 7, 2599-2611.
16. Hegelund T, Ottosson K, Rådinger M, Tomberg P and Celander MC 2004. Effects of the antifungal imidazole ketoconazole on CYP1A and CYP3A in rainbow trout and killifish. Environmental Toxicology and Chemistry 23, 1326-1334. (Pubitemid 38621041)
17. Hickman D, Wang J, Wang Y and Unadkat JD 1998. Evaluation of the selectivity of in vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities. Drug Metabolism and Disposition 26, 207-215. (Pubitemid 28182395)
18. Hosomi H, Akai S, Minami K, Yoshikawa Y, Fukami T, Nakajima M and Yokoi T 2010. An in vitro drug-induced hepatotoxicity screening system using CYP3A4-expressing and gamma-glutamylcysteine synthetase knockdown cells. Toxicology in Vitro 24, 1032-1038.
19. Kojima M, Sekimoto M and Degawa M 2008. A novel gender-related difference in the constitutive expression of hepatic cytochrome P4501A subfamily enzymes in Meishan pigs. Biochemical Pharmacology 75, 1076-1082.
20. Kullman SW, Kashiwada S and Hinton DE 2004. Analysis of medaka cytochrome P450 3A homotropic and heterotropic cooperativity. Marine Environmental Research 58, 469-473. (Pubitemid 38738915)
21. Lamb DC, Kelly DE, Waterman MR, Stromstedt M, Rozman D and Kelly SL 1999. Characteristics of the heterologously expressed human lanosterol 14α-demethylase (other names: P45014DM, CYP51, P45051) and inhibition of the purified human and Candida albicans CYP51 with azole antifungal agents. Yeast 15, 755-763. (Pubitemid 29308798)
22. Nannelli A, Chirulli V, Longo V and Gervasi PG 2008. Expression and induction by rifampicin of CAR- and PXR-regulated CYP2B and CYP3A in liver, kidney and airways of pig. Toxicology 252, 105-112.
23. Puccinelli E, Gervasi PG and Longo V 2011. Xenobiotic metabolizing cytochrome P450 in pig, a promising animal model. Current Drug Metabolism 12, 507-525.
24. Price RJ, Giddings AM, Scott MP, Walters DG, Capen CC, Osimitz TG and Lake BG 2008. Effect of Pyrethrins on cytochrome P450 forms in cultured rat and human hepatocytes. Toxicology 243, 84-95. (Pubitemid 350250962)
25. Rasmussen M, Ekstrand B and Zamaratskaia G 2011. Comparison of cytochrome P450 concentrations and metabolic activities in porcine hepatic microsomes prepared with two different methods. Toxicology in Vitro 25, 343-346.
26. Renwick AB, Surry D, Price RJ, Lake BG and Evans DC 2000. Metabolism of 7-benzyloxy-4-trifluoromethylcoumarin by human hepatic cytochrome P450 isoforms. Xenobiotica 30, 955-969.
27. Schlenk D, Celander M, Gallagher EP, George S, James M, Kullman SW, Van den Hurk P and Willett K 2008. Biotransformation in fishes. In The Toxicology of fishes (ed. RT Di Giulio and DE Hinton), pp. 154-205. CRC Press, Boca Raton, FL, USA.
28. Skaanild MT and Friis C 1999. Cytochrome P450 sex differences in minipigs and conventional pigs. Pharmacology & Toxicology 85, 174-180. (Pubitemid 29484983)
29. Smith EM and Wilson JY 2010. Assessment of cytochrome P450 fluorometric substrates with rainbow trout and killifish exposed to dexamethasone, pregnenolone-16α-carbonitrile, rifampicin, and β-naphthoflavone. Aquatic Toxicology 97, 324-333.
30. Stresser DM, Turner SD, Blanchard AP, Miller VP and Crespi CL 2002. Cytochrome P450 fluorometric substrates: identification of isoform-selective probes for rat CYP2D2 and human CYP3A4. Drug Metabolism and Disposition 30, 845-852. (Pubitemid 34671098)
31. Van der Oost R, Beyer J and Vermeulen NPE 2003. Fish bioaccumulation and biomarkers in environmental risk assessment: a review. Environmental Toxicology and Pharmacology 13, 57-149. (Pubitemid 35441240)
32. Venkatakrishnan K, von Moltke LL and Greenblatt DJ 2000. Effects of antifungal agents on oxidative drug metabolism: clinical relevance. Clinical Pharmacokinetics 38, 111-180. (Pubitemid 30122116)
33. Weber MM, Wil A, Adelmann B and Engelhardt D 1991. Effect of ketoconazole on human ovarian C17,20-desmolase and aromatase. Journal of Steroid Biochemistry and Molecular Biology 38, 213-218.
34. Zamaratskaia G, Chen G and Lundström K 2006. Effects of sex, weight, diet and hCG administration on levels of skatole and indole in the liver and hepatic activities of cytochromes P4502E1 and P4502A6 in pigs. Meat Science 72, 331-338. (Pubitemid 41563296)
35. Zamaratskaia G, Zlabek V, Chen G and Madej A 2009. Modulation of porcine cytochrome P450 enzyme activities by surgical castration and immunocastration. Animal 3, 1124-1132.
36. Zamaratskaia G and Squires EJ 2009. Biochemical, nutritional and genetic effects on boar taint in entire male pigs. Animal 3, 1508-1521.
37. Zamaratskaia G and Zlabek V 2009. EROD and MROD as markers of cytochrome P450 1A activities in hepatic microsomes from entire and castrated male pigs. Sensors 9, 2134-2147.